Form 4: Aurinia Pharmaceuticals Director MacKay-Dunn Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Director R. Hector MacKay-Dunn sold 5,630 shares of Aurinia Pharmaceuticals to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On May 21, 2024, R. Hector MacKay-Dunn, a director of Aurinia Pharmaceuticals Inc., sold 5,630 shares of common stock.
- The sale was executed at a price of $5.74 per share.
- This transaction was to cover tax withholding obligations related to the vesting of Restricted Stock Units granted on May 19, 2023.
- Following the transaction, MacKay-Dunn directly owns 18,595 shares of Aurinia Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company directors and officers. This transaction is a routine part of equity compensation and doesn't necessarily reflect a change in the director's view of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/19/2023 | Date of grant for Restricted Stock Units |
| 05/21/2024 | Date of transaction (sale of shares) |
| 05/22/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.